Home Contact Brief CV Inaugural Lecture Publications PubMed Parliament

Publications

Papers

  1. Sharp DM, Lewis E, Barton R, O’Toole L, Beavis A, Greenhaulgh A, Hutton C, Sykes M, Walker MB, Stein M, Walker LG (2022). A randomised clinical trial of relaxation therapy plus hypnotherapy (HYPREL) for patients with thoracic cancer undergoing radiotherapy. Contemporary Hypnosis and Integrative Therapy, 36, 7–22.
  2. Sharp DM, Walker AA, Green VL, Greenman J, Russell D, Russell IT, Walker MB and Walker LG (2021). Psychosocial effects of relaxation therapy and guided imagery: a pragmatic randomised controlled trial. Contemporary Hypnosis and Integrative Therapy, 35, 20-35.
  3. Walker LG (2020). Psychosocial support services for patients with cancer and their families: problems, challenges and opportunities. Personality in a changing world: health, adaptation, development. 8, 283-90. Available online
  4. Bancroft EK, Saya S, Brown E, Thomas S Taylor N, Rothwell J, Pope J, Chamberlain A, Page E, Benafif S, Hanson H, Dias A, Mikropoulos C, Izatt L, Side L, Walker L, Tomkins S, Cook J, Barwell J, Wiles V, Limb L, Eccles D, Leach MO, Shanley S, Gilbert FJ Gallagher D, Rajashanker B, Whitehouse R, Koh DM, Sohaib SA, Evans DG, Eeles RA, Walker LG (2020). The psychosocial effects of whole body MRI screening in adult high risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY). Journal of Medical Genetics, 57, 226-236. doi: 10.1136/jmedgenet-2019-106407. Epub 2019 Nov 12.
  5. McBride KA, Ballinger ML, Schlub TE, Young M, Tattersall MHN, Kirk J, Eeles R, Killick E, Walker LG, Shanley S, Thomas DM, Mitchell G. (2017). Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? Familial Cancer, 16, 423-432. doi: 10.1007/s10689-016-9964-7.
  6. Fielding S, Rothnie K, Gray N M, Little J, Cruickshank M, Neal K, Walker L G, Whynes D, Cotton S C and Sharp L (in association with the TOMBOLA group) (2016). Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial. Psychooncology, 26, 476-483. doi: 10.1002/pon.4163. Epub 2016 Jun 14.
  7. Sharp L, Cotton SC, Cruickshank ME, Gray NM, Neal K, Rothnie K, Thornton AJ, Walker LG, Little J; TOMBOLA Group. (2015). Long-term worries after colposcopy: which women are at increased risk? Women's Health Issues, 25, 517-527. doi: 10.1016/j.whi.2015.04.002. Epub 2015 Jun 4.
  8. Eremin J, Cowley G, Walker LG, Murray M, Stovickova M and Eremin O (2015). Women with large (>3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival. SpringerPlus, 4, 9. http://www.springerplus.com/ content/4/1/9
  9. Rothnie K, Cotton S C, Fielding S, Gray N M, Little, J, Cruickshank M E, Walker L G, Avis M, Sharp L (2014). Measuring the psychosocial burden in women with low-grade abnormal cervical cytology in the TOMBOLA trial: psychometric properties of the Process and Outcome Specific Measure (POSM). Health and Quality of Life Outcomes, 12:154 http://www.hqlo.com/content/12/1/154
  10. Evans DG, Kesavan N, Lim Y, Gadde S, Hurley E, Massat NJ, Maxwell AJ, Ingham S, Eeles R, Leach MO; MARIBS Group, Howell A, Duffy SW. MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Research and Treatment 2014, 145, 663-672. doi: 10.1007/s10549-014-2931-9. Epub 2014 Apr 1.
  11. Cotton SC, Sharp, L, Little J, Gray NM, Walker LG, Whynes DK, Cruickshank ME (2014). A normal colposcopy examination fails to provide psychological reassurance for women who have had low-grade abnormal cervical cytology. Cytopathology, Aug 6. doi: 10.1111/cyt.12173.
  12. Sharp L, Cotton S, Little S, Gray NM, Cruickshank M, Smart L, Thornton A, Waugh N, Walker LG, on behalf of the TOMBOLA group (2013). Psychosocial impact of alternative management policies for low-grade cervical abnormalities: results from the TOMBOLA randomised controlled trial. PLoS ONE 10.1371/journal.pone.0080092
  13. Sharp L, Cotton S, Cruickshank M, Smart L, Walker L G and Little J, on behalf of the TOMBOLA Group (2013). The unintended consequences of cervical screening: distress in women undergoing cytological surveillance. Journal of Lower Genital Tract Disease, doi: 10.1097/LGT.0b013e31829c97d8
  14. Sharma A, Walker L G and Monson J R T (2013). Baseline Quality of Life factors predict long term survival after elective resection for colorectal cancer. International Journal of Surgical Oncology, Volume 2013, Article ID 269510, 6 pages http://dx.doi.org/10.1155/2013/269510
  15. Walker LG, Eremin J, Aloysius MM, Vassanasiri W, Walker MB, El-Sheemy M, Cowley G, Beer J, Samphao S, Wiseman J, Jibril JA, Valerio D, Clarke DJ, Kamal M,Thorpe GW, Baria K and Eremin O (2011). Effects of quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breasty cancer. BMC Cancer, 11, 179.
  16. Hutton J, Walker LG, Gilbert FJ, Evans DG, Eeles R, Kwan-Lim GE, Thompson D, Pointon LJ, Sharp DM, and Leach MO on behalf of the UK Study Group for MRI Screening in Women at High Risk (MARIBS) (2011). Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS study. British Journal of Cancer, 104, 578-86.
  17. Sharp L, Cotton S, Gray N, Avis M, Russell I, Walker L, Waugh N, Whynes D, Woolley C, Thornton A, Smart L, Cruickshank M and Little J on behalf of the TOMBOLA Group (2011). Long-term psychosocial impact of alternative management policies in women with low-grade abnormal cervical cytology referred for colposcopy: a randomised controlled trial. British Journal of Cancer, 104, 255 - 264.
  18. Sharma A, Greenman J, Walker LG, Monson JR (2010). Differences in cytokine levels due to gender in colorectal cancer patients. Cytokine, 50, 91-93.
  19. Green VL, Alexandropoulou A, Walker MB, Walker AA, Sharp DM, Walker LG, and Greenman G (2010). Alterations in the Th1/Th2 balance in breast cancer patients using reflexology and scalp Massage. Experimental and Therapeutic Medicine, 1, 97-108.
  20. Turnbull LW, Brown SR, Olivier C, Harvey I, Brown J, Drew P, Hanby A, Manca A, Napp V, Sculpher M, Walker LG, Walker S; on behalf of the COMICE Trial Group (2010). Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technology Assessment, 14, 1-182.
  21. Sharp DM, Walker MB, Bateman JS, Braid F, Hebblewhite C, Hope T, Lines M, Walker AA, Walker LG (2009). Demographic characteristics of patients using a fully integrated psychosocial support service for cancer patients. BMC Research Notes, Dec 15; 2:253. doi: 10.1186/1756-0500-2-253.
  22. Tombola Group (2009). Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ, 339:b2546 doi:10.1136/bmj.b2546
  23. Sharp DM, Walker MB, Chaturvedi A, Upadhyay S, Hamid A, Walker A, Bateman JS, Braid F, Ellwood K, Hebblewhite C, Hope T, Lines M and Walker LG (2009). A randomised controlled trial of the psychological effects of reflexology in early breast cancer. European Journal of Cancer, doi:10.1016/j.ejca.2009.10.006.
  24. Eremin O, Walker M B, Simpson E, Heys S D, Ah-See A K, Hutcheon A W, Ogston K N, Sarkar T K, Segar A, and Walker L G (2009). Immuno-modulatory effects of relaxation training and guided imagery in women with locally advanced breast carcinoma undergoing multimodality treatment: A randomised controlled trial. The Breast, 18, 17-25.
  25. Gilbert FJ, Warren RM, Kwan-Lim G, Thompson DJ, Eeles RA, Evans DG, Leach MO; United Kingdom Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group (2009). Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features. Radiology, 252, 358-368.
  26. Walker, LG. (2009). Psycho-Science: where do we go from here? European Journal of Cancer, 45, Suppl 1, 455-456.
  27. Sharma A, Sharp D M, Monson JRT and Walker LG (2008). Patient personality predicts postoperative stay after colorectal cancer resection. Colorectal Disease, 10, 151-156.
  28. Sharma A, Sharp D, Walker LG and Monson JRT (2008). Stress and burnout among colorectal surgeons and colorectal nurse specialists working in the NHS. Colorectal Disease10, 397-406.
  29. Sharma A, Sharp DM, Walker LG and Monson JRT (2008). Stress and burnout among colorectal and vascular surgical consultants working in the NHS. Psycho Oncology,17, 570-576.
  30. Sharma A, Sharp DM, Walker LG and Monson JRT (2008). Colorectal MDTs: the team's perspective. Colorectal Disease, 10, 63-68.
  31. Thomas R, Williams M, Marshall C, Allerton R and Walker L (2008). Switching to letrozole or exemestane improves hot flushes, mood and quality of life in tamoxifen intolerant women. British Journal of Cancer, 98, 1494-1499.
  32. Sharma A, Greenman J, Sharp DM, Walker LG, Monson JRT (2008). Vascular endothelial growth factor and psychosocial factors in colorectal cancer. Psycho-Oncology 17, 66-73.
  33. Sharma, A, Sharp DM, Walker LG and Monson JRT (2007). Predictors of early postoperative quality of life after elective resection for colorectal cancer. Annals of Surgical Oncology, 14, 3435-3342.
  34. Sharma A, Walker AA, Sharp DM, Monson JRT and Walker L G (2007). Psychosocial factors and quality of life in colorectal cancer. The Surgeon, 5, 344-354.
  35. Walker LG, Walker AA, Walker MB and Sharp DM (2007). Relaxation, visualisation, and hypnotherapy. In Barraclough J. Enhancing Cancer Care: Complementary, Expressive and Supportive Therapies in Oncology. Oxford, Oxford University Press.
  36. Iwuagwu O, Stanley P, Platt A, Drew P, Walker L (2006). Effects of bilateral breast reduction on anxiety and depression: Results of a prospective randomised trial. Scandinavian Journal of Plastic Reconstruction Surgery and Hand Surgery, 40, 19-23.
  37. Iwuagwu O C, Walker LG, Stanley PW, Hart NB, Platt AJ, Drew PJ (2006). Randomized clinical trial examining psychosocial and quality of life benefits of bilateral breast reduction surgery. British Journal of Surgery, 93, 291-4.
  38. Gray NM, Sharp L, Cotton SC, Masson L F, Little J, Walker L G, Avis M, Philips Z, Russell I and Whynes D (2006). Psychological effects of a low-grade abnormal smear test result: anxiety and associated factors. British Journal of Cancer, 94, 253-262.
  39. Klaber Moffett J, Jackson DA, Gardiner ED, Torgerson DJ, Coulton S, Eaton S, Mooney MP, Pickering C, Green, AJ and Walker LG (2006). Comparison of ‘McKenzie’ physical therapy treatment vs a brief physiotherapy intervention: A randomised clinical trial of neck pain and back pain patients in primary care. Rheumatology, Oct 24; [Epub ahead of print].
  40. Griebsch I, Brown J, Boggis C, Dixon A, Dixon M, Easton D, Eeles R, Evans DG, Gilbert FJ, Hawnaur J, Kessar P, Lakhani SR, Moss SM, Nerurkar A, Padhani AR, Pointon L, Potterton J, Thompson D, Turnbull LW, Walker LG, Warren R, Leach MO for the UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group (2006). Cost-effectiveness of contrast enhanced magnetic resonance imaging versus X-ray mammography of women at a high familial risk of breast cancer. British Journal of Cancer, 95, 801-810.
  41. Sharp L, Cotton SC, Alexander L, William S E, Gray N M, Reid JM on behalf of the TOMBOLA group (2006). Reasons for participation and non-participation in a randomised controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears). Clinical Trials, 3, 431-442.
  42. MARIBS Study Group (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). The Lancet, 365, 1769-1778.
  43. Gray NM, Sharp L, Cotton S, Aves M, Philips Z, Russell I, Walker L G, Whynes D, Little J (2005). Developing a questionnaire to measure the psychosocial impact of an abnormal cervical smear result and its subsequent management: the TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) trial. Quality of Life Research,14, 1553-1562.
  44. Walker LG (2004). Hypnotherapeutic insights and interventions: a cancer odyssey. Contemporary Hypnosis, 21, 35-45.
  45. Walker LG (2004). Integrative Tumor Board: recurrent lymphoma. Biopsychosocial perspective. Integrative Cancer Therapies, 3, 250-254.
  46. Leach MO, Eeles R A, Turnbull L W, Dixon A K, Brown J, Hoff RJ, Coulthard A, Dixon J M, Easton D F, Evans D G, Gilbert F J, Hawnaur J, Hayes C, Kessar P, Lakhani S, Liney G, Moss S M, Padhani A P, Pointon L J, Sydenham M, Walker L G et al. (2003). The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). Journal of Experimental Clinical Cancer Research, 21, 107-14.
  47. Keith D, Walker MB, Walker LG, Heys SD, Sarkar TK, Hutcheon AW and Eremin O (2003). Women who wish breast reconstruction: characteristics, fears and hopes. Plastic & Reconstructive Surgery, 111, 1051-1056.
  48. Walker LG, Walker MB and Sharp DM (2003). Psychosocial oncology services for women with breast cancer. Trends in Urology, Gynaecology and Sexual Health, 8, 25-32.
  49. Smith IC, Heys SD, Hutcheon AW, Payne S, Miller ID, Gilbert FJ, Ah-See AK, Eremin O, Walker LG, Walker MB, Sarkar TK, Ogston KN (2002). Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. Journal of Clinical Oncology, 20, 1456-1466.
  50. Degenhard A, Tanner C, Hayes C, Hawkes DJ, Leach MO on behalf of the UK MRI Breast Screening Study (2002). Comparison between radiological and artificial neural network diagnosis in clinical screening. Physiological Measurement, 23, 727-39.
  51. Dick F, Semple S, Osborne A, Soutar A, Seaton A, Cherrie J W, Walker L G, Haites N. (2002) Organic solvent exposure, genes, and risk of cognitive impairment. Quarterly Journal of Medicine, 95, 379-387.
  52. Heys SD, Hutcheon AW, Sarkar TK, Ogston KN, Miller ID, Payne S, Smith I, Walker LG, Eremin O. (2002) Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial. Clinical Breast Cancer, Oct 3, Suppl 2:S69-74.
  53. Dagenhard A, Tanner C, Hayes C, Hawkes D J, Leach M O and the UK MRI Breast Screening Study (2002). Comparison between radiological and artificial neural network diagnosis in clinical screening. Physiological Measurement, 23, 727-739.
  54. Warren R M L, Pointon L, Caines R, Hayes C, Thompson D, Leach M O and the UK MRI Breast Screening Study (MARIBS) (2002). What is the recall rate of breast MRI when used for screening asymptomatic women at high risk? Magnetic Resonance Imaging, 20, 557-565.
  55. Chen R, Dick F, Semple S, Seaton A and Walker LG (2001) Solvent exposure and personality. Occupational and Environmental Medicine, 58, 14-18.
  56. Eagles JM and Walker LG (2001). A comparison of real patients, suimulated patients and videotaped interviews in teaching medical students about alcohol misuse. Medical Teacher, 23, 490-493.
  57. Harding L, Walker L G, Lloyd D and Duffty P (2001). A controlled study of children born at gestation 28 weeks or less: psychological characteristics at seven to ten years of age. Health Bulletin, 59, 81-90.
  58. Klein S, Kitchener H C, Tracy D and Walker LG (2000). The effects of cancer patient participation in teaching communication skills to medical undergraduates: a follow-up evaluation. European Journal of Cancer, 36, 273-81.
  59. Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, Leach MO, Moss SM, Padhani AP, Pointon LJ, Ponder BA, Sloane JP, Turnbull LW, Walker LG, Warren RM, Watson W (2000). Rationale for magnetic resonance imaging screening in women at high genetic risk of breast cancer. The Breast 9, 72-77.
  60. Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, Leach MO, Moss SM, Padhani AP, Pointon LJ, Ponder BA, Sloane JP, Turnbull LW, Walker LG, Warren RM, Watson W (2000). Protocol for magnetic resonance imaging screening in women at high genetic risk of breast cancer. The Breast, 9 78-82.
  61. Warren R, Hayes C and the Advisory Group of the UK study of screening for breast cancer (MARIBS) (2000). Localisation of breast lesions shown only on MRI - a review of the UK study of MRI screening for breast cancer. British Journal of Radiology, 73, 123-132.
  62. Walker L G (2000). Psychoneuroimmunology. Cancer Topics, 11, 17-19.
  63. Alexander D A and Walker L G (2000). Is my stress greater than yours? A comparison of police officers and firemen. International Journal of Police Science and Management, 2, 303-312.
  64. Brown J, Buckley D, Coulthard A, Dixon A K, Dixon, J M, Easton D F, Eeles R A, Evans D G R, Gilbert F J, Graves M, Hayes C, Jenkins J P R, Jones A P, Keevil S F, Leach M O, Liney G P, Moss S M, Padhani A R, Parker G J M, Pointon L J, Ponder B A J, Redpath T, Sloane J P, Turnbull L W, Walker L G and WarrenR M L (2000). Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. Magnetic Resonance Imaging, 18, 765-776.
  65. Stewart A, Porter R W, Primrose W R, Walker L G and Reid D M (1999). Cervical and trochanteric hip fractures: bone mass and other parameters. Clinical Rheumatology, 18, 201-206.
  66. Walker L G, Walker M B, Heys S D, Ogston K, Miller I, Hutcheon A W, Sarkar TK and Eremin O (1999). The psychological, clinical and pathological effects of relaxation training and imagery during primary chemotherapy. British Journal of Cancer, 80, 262-268.
  67. Heys S D, Walker L G, Smith I and Eremin O (1999). Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Annals of Surgery, 229, 467-477. (Special Feature).
  68. Walker L G and Anderson J (1999). Testing complementary and alternative medicine within a research protocol. European Journal of Cancer, 35, 1614-1618. (Invited contribution for Special Edition edited by M Slevin and J Mossman).
  69. Walker L G, Heys SD, Walker M B, Ogston K, Miller I, Hutcheon A W, Sarkar T K, Ah-See A K and Eremin O (1999). Psychological factors can predict the response to primary chemotherapy in women with locally advanced breast cancer. European Journal of Cancer, 35, 1783-1788.
  70. Stewart A, Primrose WR, Walker LG, Reid DM (1999). Risk factors associated with increased falls in a hip fracture population. Gerontology, 45, 233.
  71. Walker L G (1999). Psychological interventions, host defences and survival. Advances in Mind-Body Medicine, 15, 236-281. (Invited comment on Greer S ‘Mind-Body Research in Psycho Oncology.’)
  72. Stewart A, Walker L G, Porter R W, Reid D M and Primrose W (1999). Predicting a second hip fracture. Journal of Clinical Densitometry, 2, 363-370.
  73. Walker L G, Heys S D and Eremin O (1999). Surviving cancer: does the fighting spirit help? Journal of Psychosomatic Research. 47, 497-503. (Invited Editorial.)
  74. Twelves CJ, Thomson CS, Young J and Gould A for the Scottish Breast Cancer Focus Group and the Scottish Cancer Therapy Network (1998). Entry into clinical trials in breast cancer: the importance of specialist teams. European Journal of Cancer, 34, 1004-1007.
  75. Twelves CJ, Thomson CS, Gould A and Dewar J for the Scottish Breast Cancer Focus Group and the Scottish Cancer Therapy Network (1998). Variation in the survival of women with breast cancer in Scotland. British Journal of Cancer, 78, 566-571.
  76. Walker L G (1998). Hypnosis and cancer: host defences, quality of life and survival. Contemporary Hypnosis, 15, 34-39.
  77. Walker L G, Köhler C, Heys S D and Eremin O (1998). Psychosocial aspects of cancer in the elderly. European Journal of Surgical Oncology, 24, 375-378.
  78. Heys S D, Ogston K, Miller I, Hutcheon A W, Walker L G, Sarkar T K, Dewar J, Ah-See A K, and Eremin O (1998). Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial. International Journal of Oncology, 12, 221-225.
  79. Heys S D, Walker L G and Eremin O (1998). Serum albumin: an independent prognostic indicator in colorectal cancer. Journal of the Royal College of Surgeons of Edinburgh, 43, 163-168.
  80. Heys S D, Langlois N, Smith I C, Walker L G and Eremin O (1998). NM23 gene product expression does not predict lymph node metastasis or survival in young patients with colorectal cancer. Oncology Reports, 5, 735-739.
  81. Eltahir A, Heys S D, Hutcheon A W, Sarkar T K, Walker L G, Ah-See A K and Eremin O (1998). Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. American Journal of Surgery, 175, 127-132.
  82. Gruzelier J, Clow A, Evans P, Lazar I and Walker L (1998). Mind-body influences on immunity: lateralised control, stress, individual difference predictors and prophylaxis. Annals of the New York Academy of Science, 851, 487-494.
  83. Gilbert F J, Cordiner C M, Affleck I R, Hood D B, Mathieson D and Walker L G (1998). Breast screening: the psychological costs of false positive recall in women with and without a history of breast cancer. European Journal of Cancer, 34, 2010-2014.
  84. Heys SD, Ogston KN, Simpson WG, Walker LG, Hutcheon AW, Sarkar TK, and Eremin O (1998). Acute phase proteins in patients with large and locally advanced breast cancer treated with neo-adjuvant chemotherapy: response and survival. International Journal of Oncology, 13, 589-594.
  85. Wesnes K A, Walker M B, Heys S D, White L, Warren R, Walker L G and Eremin O (1997). What does a weekend 'on call' in a surgical ward do to cognitive performance and mood? British Journal of Surgery, 84, 493-495.
  86. Heys S D, Walker L G and Eremin O (1997). The value of peri-operative nutritional support in the sick patient. Proceedings of the Nutrition Society, 56, 443-457.
  87. Langlois N, Walker L G, Eremin O and Heys S D (1997). Expression of growth factor receptors are not prognostic indicators in young patients with colorectal cancer. Journal of the Royal College of Surgeons of Edinburgh, 42, 98-101.
  88. Fox H, Walker L G, Heys S D, Ah-See A K, and Eremin O (1997). Are patients with mastalgia anxious, and does relaxation therapy help? The Breast, 6, 138-142.
  89. Walker L G, Walker M B, Heys, S D, Lolley J, Wesnes K and Eremin O (1997). The psychological and psychiatric effects of rIL-2: a controlled clinical trial. Psycho-Oncology. 6, 290-301.
  90. MR Breast Screening Advisory Group (1997). National study of MRI screening for women at genetic risk of breast cancer. The Lancet, July 5th. (Also on http://www.thelancet.com/lancet/ writing/writing4.html).
  91. Walker L G and Eremin O (1996). Psychological assessment and intervention: future prospects for women with breast cancer. Seminars in Surgical Oncology, 12, 76-83.
  92. Johnson V C, Walker L G, Whiting P H Heys S D and Eremin O (1996). Can relaxation training and hypnotherapy modify the immune response to acute stress, and is hypnotisability relevant? Contemporary Hypnosis, 13, 100-108.
  93. Alexander D A and Walker L G (1996). The perceived impact of police work on police officer's spouses and their families. Stress Medicine, 12, 239-246.
  94. Walker L G (1996). Communication skills: when, not if, to teach. European Journal of Cancer, 32A, 1457-1459 (Invited Editorial).
  95. Walker L G (1996). Behavioural oncology: psychological aspects of treating and understanding malignant disease. European Journal of Surgical Oncology, 22, 546-550.
  96. Walker L G, Wesnes K A, Heys S D, Walker M B, Lolley J and Eremin O (1996). The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments. European Journal of Cancer, 32A, 2275-2283.
  97. Ratcliffe M A, Dawson A A and Walker L G (1995). Eysenck Personality Inventory L-scores in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Psycho-Oncology, 4, 39-45.
  98. Walker L G and Eremin O (1995). Psychoneuroimmunology: new fad or the fifth therapeutic modality? American Journal of Surgery, 170, 2-4 (Invited Editorial).
  99. Alexander D A and Walker L G (1994). The methods used by Scottish police officers to cope with work-induced stress. Stress Medicine, 10, 131-138.
  100. Walker L G, Cordiner C M, Gilbert F J, Needham G, Deans H E, Affleck I R, Hood D B, Mathieson D, Ah-See A K, and Eremin O (1994). How distressing is attendance for routine breast screening? Psycho-Oncology, 3, 299-304.
  101. Paraskevaidis E, Kitchener H C and Walker L G (1993). Doctor-patient communication and subsequent mental health in women with gynaecological cancer. Psycho-Oncology, 2, 195-200.
  102. Walker L G, Johnson V C and Eremin O (1993). Modulation of the immune response to stress by hypnosis and relaxation training in normals: a critical review. Contemporary Hypnosis, 10, 19-27.
  103. Walker L G (1992). Hypnosis and cancer. American Journal of Preventive Psychiatry and Neurology, 3 (3), 42-49.
  104. Beattie J G and Walker L G (1991). Drug treatment of anxiety: the general practitioner's perspective. Update: The Journal of Continuing Education for General Practitioners, May 15, 1008-1016.
  105. Walker L G (1991). Some psychological and psychiatric aspects of cancer. Aberdeen Postgraduate Medical Bulletin, 25, 3, 11-16.
  106. Walker L G (1990). The measurement of anxiety. Postgraduate Medical Journal, 66 (Suppl), 11-17.
  107. Patten M and Walker L G (1990). Marriage Guidance Counselling: 1. What clients think will help. British Journal of Guidance and Counselling, 18, 28-39.
  108. Walker L G and Patten M (1990). Marriage Guidance Counselling: 2. What counsellors want to give. British Journal of Guidance and Counselling, 18, 293-306.
  109. Walker L G, Dawson A A, Pollet S M, Ratcliffe M A and Hamilton L (1988). Hypnotherapy for chemotherapy side effects. British Journal of Experimental and Clinical Hypnosis, 5, 79-82.
  110. Walker L G and Baird P (1988). The effects of marriage guidance training on the trainee's own marriage: a prospective study. British Journal of Guidance and Counselling, 16, 176-189.
  111. Walker L G, Dawson A A, Ratcliffe M A and Lolley J (1988). Sick to death of it: psychological aspects of cytotoxic chemotherapy side effects. Aberdeen Postgraduate Medical Bulletin, 22, 11-17.
  112. Eagles J M, Walker L G, Blackwood G W and Restall D (1987). The mental health of elderly couples: II. Concordance for neurotic morbidity in spouses. British Journal of Psychiatry, 150, 303-308.
  113. Baird P and Walker L G (1986). Perceived marital changes following marriage guidance training. British Journal of Guidance and Counselling, 14, 205-211.
  114. Walker L G, Blitz N and Howe E (1985). The Camphill Rudolf-Steiner Schools: a unique national resource providing integrated guidance and care. Association for Child Psychology and Psychiatry Newsletter, 7, 12-15.
  115. Walker L G, Thomson N and Lindsay W R (1984). Assessing family relationships: a multi-method, multi-situational approach. British Journal of Psychiatry, 144, 383-394.
  116. Besson J A O and Walker L G (1983). Hypnotherapy for writer's cramp. Lancet, 1 Jan, 71-72.
  117. Walker L G, Haldane J D and Alexander D A (1981). A medical curriculum: evaluation by final year students. Medical Education, 15, 377-382.
  118. Walker L G (1979). The effect of some incentives on the work performance of psychiatric patients at a rehabilitation workshop. British Journal of Psychiatry, 134, 427-435.
  119. Haldane J D, Alexander D A, Hebditch J G, Walker L G (1979). Training in psychotherapy. The Aberdeen University Diploma Course: second report. Bulletin, Royal College of Psychiatrists, (September), 131-134.
  120. Walker L G, Adamson F P C, Alexander D A and Stoffelmayr B E (1973). A negative correlation between improved productivity in a psychiatric rehabilitation unit and social behaviour outside. British Journal of Psychiatry, 123, 409-412.